CDC Recommends Pneumococcal Vaccination for Adults 50 Years and Older

Age Recommendation Change:
The CDC has lowered the age for pneumococcal vaccination from 65 to 50 years old, following the recommendation of the Advisory Committee on Immunization Practices (ACIP).

Risk and Prevention:
Pneumococcal bacteria can cause serious illnesses such as pneumonia, meningitis, and bloodstream infections, with older adults being at increased risk. Vaccination is crucial for protection against these diseases.

Vaccination Guidance:
Adults 50 years or older should consult with a healthcare provider to ensure they are up to date with pneumococcal vaccination, especially in preparation for the winter respiratory season.

Vaccine Tools:
The PneumoRecs VaxAdvisor app has been updated to reflect the new recommendations, providing healthcare providers with a tool to determine which pneumococcal vaccines a patient needs and when.

Vaccine Types: There are two types of pneumococcal vaccines used in the United States:
pneumococcal conjugate vaccines (PCVs) and pneumococcal polysaccharide vaccine (PPSV23).

Vaccination Locations:
Adults can receive pneumococcal vaccines at healthcare provider offices, pharmacies, or federally funded health centers.